期刊文献+

健脾疏肝活血方对H_(22)肝癌小鼠免疫器官的影响 被引量:5

Influence of Jianpishuganhuoxue decoction on immune organs in H_(22) hepatic cancer mice
下载PDF
导出
摘要 目的探讨健脾疏肝活血方对H22肝癌小鼠免疫器官的影响。方法采用细胞接种的方法建立小鼠H22肝癌动物模型,将小鼠分为正常组,模型组,环磷酰胺组,健脾疏肝活血方低、中、高剂量组,观察各组小鼠的整体情况。15 d后取血清、胸腺、脾及肝癌组织,观察健脾疏肝活血方的抑瘤效应和对免疫器官的影响。结果成功建立小鼠H22肝癌动物模型,健脾疏肝活血方能改善肝癌小鼠的整体情况,提高脾指数和胸腺指数。结论健脾疏肝活血方对H22肝癌小鼠的免疫器官(脾、胸腺)有一定的保护作用。 Objective It is to discuss the effect of Jianpishuganhuoxue decoction(JPSGHXD) on immune organs in H22 hepatic cancer mice.Methods Animal model of H22 hepatic cancer of mice were established by inoculating tumor cell.The the mice were randomly divided into six groups: normal group,model group,CTX group,low-dose,middle-dose and high-dose group of JPSGHXD.The mice's overall condition in each group was observed.In 15 days later,the mice's serum,thymus,spleen and cancerous tissue was gotten to observe the suppressing effect of JPSGHXD on tumor growth and the influence on immune organs.Results the H22 hepatic cancer models were established successfully.JPSGHXD could improve the whole condition of tumor-bearing mice,and enhance their spleen index and thymus index.Conclusion JPSGHXD has a protecting effect on immune organs(spleen and shymus) of H22 hepatic cancer mice.
作者 郑东升 国佳
机构地区 浙江中医药大学
出处 《现代中西医结合杂志》 CAS 2011年第19期2356-2357,2470,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
基金 浙江省中医药青年基金资助项目(2006Y022) 浙江省教育厅基金资助项目(20071138) 浙江省高校青年教师资助计划项目
关键词 健脾疏肝活血方 胸腺指数 脾指数 肝癌 Jianpishuganhuoxue decoction spleen index thymus index hepatic cancer
  • 相关文献

参考文献1

二级参考文献17

共引文献7

同被引文献94

  • 1连云岚,杨中林.北虫草化学成分及药理作用研究进展[J].山西医药杂志,2006,35(1):44-46. 被引量:65
  • 2马建,虞亚明,张世明,刘波,涂禾,邹明,刘卫东.服用健脾生血补肾中药划船运动员大运动量训练后血红蛋白及免疫球蛋白等指标的变化[J].中国临床康复,2006,10(27):16-18. 被引量:14
  • 3孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生出版社,2008:371.
  • 4蔡友华,刘学铭.虫草素的研究与开发进展[J].中草药,2007,38(8):1269-1272. 被引量:49
  • 5司徒镇强 吴军正.细胞培养[M].西安:世界图书版出版公司,2004.78-202.
  • 6De CC,Lin LJ,Kao ST,et al.Inhibitory effects of Zuo-Jin-Wan andits alkaloidal ingredients on activator protein 1,nuclear factor-κB,and cellular transformation in HepG2 cells[J].Fitoterapia,2011,82(4):696–703.
  • 7Finn RS.Development of molecularly targeted therapies in hepat-ocellular carcinoma:where do we go now?[J].Clin Cancer Res,2010,16(2):390–397.
  • 8Jemal A,Siegel R,Ward E,et al.Cancer statistics,2008[J].CA CancerJ Clin,2008,58(2):71-96.
  • 9Tang ZY.Liver transplantation:A simple inflammation markerpredicts liver cancer prognosis[J].Nat Rev Gastroenterol Hepatol,2011,8(7):367-368.
  • 10Avila MA,Berasain C,Sangro B,et al.New therapies for hepatoc-ellularcarcinoma[J].Oncogene,2006,25(27):3866–3884.

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部